Original Source(s)
Related Content
ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer
Vincent (Wenxin) Xu, MD , shows among patients with advanced kidney cancer on immunotherapy alone, KIM-1 reductions were seen in immune-inflamed tumors, while no KIM-1 drop was linked to immune-depleted tumors.
November 17, 2026
-
1 min
Naive-Like T Cells Linked to CAR T Durability
Higher proportions of less-differentiated T cells were associated with longer progression-free survival in a 783-patient lymphoma analysis
November 4, 2026
-
3 min